Manuel Röhrich
Impact in
- Oncology top 1%
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 37
- Peptidase Inhibition and Analysis 35
-
- Protease and Inhibitor Mechanisms 24
- Co-authors
- Uwe Haberkorn (29 shared papers)Frederik L. Giesel (27 shared papers)Jürgen Debus (19 shared papers)Clemens Kratochwil (22 shared papers)Sebastian Adeberg (13 shared papers)Hendrik Rathke (12 shared papers)Paul Flechsig (7 shared papers)Hans‐Ulrich Kauczor (10 shared papers)
- Journals
- Journal of Nuclear Medicine (14 papers)European Journal of Nuclear Medicine and Molecular Imaging (8 papers)Cancers (4 papers)Radiotherapy and Oncology (3 papers)Biomedicines (2 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Manuel Röhrich
48 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 2.1k
- Cancer Research 1.1k
- Radiology, Nuclear Medicine and Imaging 671
- Surgery 1.0k
- Cellular and Molecular Neuroscience 361
Countries citing papers authored by Manuel Röhrich
This map shows the geographic impact of Manuel Röhrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Röhrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Röhrich more than expected).
Fields of papers citing papers by Manuel Röhrich
This network shows the impact of papers produced by Manuel Röhrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Röhrich. The network helps show where Manuel Röhrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Manuel Röhrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer Hit paper breakdown → | 2019 | 964 |
| 2 | 2011 | 195 | |
| 3 | 2020 | 192 | |
| 4 | 2020 | 140 | |
| 5 | 2021 | 122 | |
| 6 | 2019 | 110 | |
| 7 | 2021 | 105 | |
| 8 | 2019 | 58 | |
| 9 | 2020 | 53 | |
| 10 | 2019 | 48 | |
| 11 | 2021 | 48 | |
| 12 | 2021 | 42 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 37 | |
| 15 | 2022 | 31 | |
| 16 | 2020 | 30 | |
| 17 | 2022 | 26 | |
| 18 | 2023 | 23 | |
| 19 | 2018 | 20 | |
| 20 | 2023 | 18 |
About Manuel Röhrich
Manuel Röhrich is a scholar working on Oncology, Cancer Research, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (35 papers), Protease and Inhibitor Mechanisms (24 papers), Cardiac Structural Anomalies and Repair (18 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Medical Imaging Techniques and Applications (5 papers), Neuropeptides and Animal Physiology (5 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.1k citations), Radiology, Nuclear Medicine and Imaging (671 citations), Surgery (1.0k citations) and Cellular and Molecular Neuroscience (361 citations). Manuel Röhrich has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Uwe Haberkorn, Frederik L. Giesel, Jürgen Debus, Clemens Kratochwil, Sebastian Adeberg, Hendrik Rathke, Paul Flechsig, Hans‐Ulrich Kauczor, Thomas Lindner and Dirk Jäger. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Cancers, Radiotherapy and Oncology and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.